Title: pharmacokinetic and oral bioavailability studies in rats. Period of performance: 4/16/2021 to 4/15/2022 severable - fixed price type task order
Ended Awarded Last action
- Contract number
- 75N91021F00001
- Awardee
-
University Of Pittsburgh - Of The Commonwealth System Of Higher Education UEI MKAGLD59JRL1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $103,177
Award facts
- Opportunity
-
- TORFPJ Solicitation number
- Contract value 80% obligated
-
- $103,177.00 Current, with exercised options
- $128,971.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15213, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $25,794 | |
| Original award | $77,383 |
About this award
This is a $128,971.00 fixed-price delivery order awarded by the National Cancer Institute to the University of Pittsburgh, a state-related research university in Pennsylvania. The contract is for pharmacokinetic and oral bioavailability studies in rats to support the development of cancer treatments. It is a task order under the Pharmacokinetic and Pharmacology Evaluations for Cancer Patients Indefinite Delivery Contract, which allows the National Cancer Institute to rapidly initiate new preclinical studies in support of its mission. The period of performance is from April 16, 2021 to April 15, 2022. This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Cancer Institute (National Institutes of Health) on April 16, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $103,177 on 75N91021F00001. Its potential value, with all options, is $128,971.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a delivery order under HHSN261201600022I, an indefinite delivery contract, on Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award